Domino hepatocyte transplantation using explanted human livers with metabolic defects attenuates D-GalN/LPS-induced acute liver failure

• Published in: Journal of translational medicine 2022-10, Vol.20 (1), p.1-479, Article 479
• Main Authors: Zhou, Guang-Peng, Li, Shi-Peng, Jiang, Yi-Zhou, Sun, Jie, Tan, Yu-Le, Zeng, Zhi-Gui, Wei, Lin, Qu, Wei, Sun, Li-Ying, Zhu, Zhi-Jun
• Format: Article
• Language: English
• Subjects: Acute liver failure; Alanine transaminase; Albumin; Analysis; Apoptosis; Aspartate aminotransferase; Biological markers; Blood & organ donations; Care and treatment; Cytokeratin; D-Galactosamine; Domino hepatocyte transplantation; Enzyme-linked immunosorbent assay; Enzymes; Experiments; Glycogen; Hepatocytes; Human primary hepatocyte; Inflammation; Inherited metabolic liver disease; Interleukin 6; Laboratories; Lipopolysaccharides; Liver; Liver cells; Liver diseases; Liver failure; Liver transplants; Localization; Metabolic disorders; Mortality; Patients; Pediatrics; Serum levels; Stem cells; Transplantation; Tumor necrosis factor-TNF; Tumor necrosis factor-α
• ISSN: 1479-5876; 1479-5876
• DOI: 10.1186/s12967-022-03674-3

Background Explanted livers from patients with inherited metabolic liver diseases possess the potential to be a cell source of good-quality hepatocytes for hepatocyte transplantation (HT). This study evaluated the therapeutic effects of domino HT using hepatocytes isolated from explanted human livers for acute liver failure (ALF). Methods Isolated hepatocytes were evaluated for viability and function and then transplanted into d-galactosamine/lipopolysaccharide-induced ALF mice via splenic injection. The survival rate was analyzed by the Kaplan-Meier method and log-rank test. Liver function was evaluated by serum biochemical parameters, and inflammatory cytokine levels were measured by ELISA. The pathological changes in the liver tissues were assessed by hematoxylin-eosin staining. Hepatocyte apoptosis was investigated by TUNEL, and hepatocyte apoptosis-related proteins were detected by western blot. The localization of human hepatocytes in the injured mouse livers was detected by immunohistochemical analyses. Results Hepatocytes were successfully isolated from explanted livers of 10 pediatric patients with various liver-based metabolic disorders, with an average viability of 85.3% [+ or -] 13.0% and average yield of 9.2 x 10.sup.6 [+ or -] 3.4 x 10.sup.6 cells/g. Isolated hepatocytes had an excellent ability to secret albumin, produce urea, uptake indocyanine green, storage glycogen, and express alpha 1 antitrypsin, albumin, cytokeratin 18, and CYP3A4. Domino HT significantly reduced mortality, decreased serum levels of alanine aminotransferase and aspartate aminotransferase, and improved the pathological damage. Moreover, transplanted hepatocytes inhibited interleukin-6 and tumor necrosis factor-[alpha] levels. Domino HT also ameliorates hepatocyte apoptosis, as evidenced by decreased TUNEL positive cells. Positive staining for human albumin suggested the localization of human hepatocytes in ALF mice livers. Conclusion Explanted livers from patients with inheritable metabolic disorders can serve as a viable cell source for cell-based therapies. Domino HT using hepatocytes with certain metabolic defects has the potential to be a novel therapeutic strategy for ALF. Keywords: Domino hepatocyte transplantation, Acute liver failure, Inherited metabolic liver disease, Human primary hepatocyte